MUTATION OF THE SERINE 15 PHOSPHORYLATION SITE OF HUMAN P53 REDUCES THE ABILITY OF P53 TO INHIBIT CELL-CYCLE PROGRESSION

被引:0
|
作者
FISCELLA, M
ULLRICH, SJ
ZAMBRANO, N
SHIELDS, MT
LIN, D
LEESMILLER, SP
ANDERSON, CW
MERCER, WE
APPELLA, E
机构
[1] NIH,CELL BIOL LAB,BETHESDA,MD 20892
[2] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107
[3] BROOKHAVEN NATL LAB,DEPT BIOL,UPTON,NY 11973
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of wild-type p53 prevents cells from entering the S phase of the cell cycle. The amino-terminal transactivation region of p53 is phosphorylated by several protein kinases, including DNA-PK, a nuclear serine/threonine protein kinase that in vitro requires DNA for activity. DNA-PK was recently shown to phosphorylate serines 15 and 37 of human p53 (Lees-Miller et al, 1992. Mol. Cell. Biol., 12, 5041-5049). To prevent phosphorylation at these sites, mutants were constructed that changed the codons for serine 15 or serine 37 to alanine codons. Expression of p53-Ala-37 in stably transformed T98G cells blocked progression of the cells into S phase as well as did the expression of wild-type p53. In contrast, p53-Ala-15 was partially defective in blocking cell cycle progression. Several cell clones transformed with the mutant p53-Ala-15 gene expressed normal levels of p53 mRNA but accumulated little or no detectable p53 protein. However, by using a transient expression system driven by a strong cytomegalovirus promoter, we showed that the inability of p53-Ala-15 to fully block cell cycle progression was not due to inadequate levels of expression or to a failure of the mutant protein to accumulate in the nucleus. These results suggest that phosphorylation of Ser-15 may affect p53 function.
引用
收藏
页码:1519 / 1528
页数:10
相关论文
共 50 条
  • [1] P53 CONTROL OF CELL-CYCLE PROGRESSION
    MOWAT, M
    STEWART, N
    HICKS, G
    LITCHFIELD, D
    PARASKEVAS, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 171 - 171
  • [2] Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction
    Puehringer-Oppermann, Franziska
    Stahl, Michael
    Keller, Gisela
    Sarbia, Mario
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (07) : 433 - 438
  • [3] Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction
    Franziska Pühringer-Oppermann
    Michael Stahl
    Gisela Keller
    Mario Sarbia
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 433 - 438
  • [4] REGULATION OF TRANSFORMATION AND THE CELL-CYCLE BY P53
    ZAMBETTI, GP
    QUARTIN, RS
    MARTINEZ, J
    GEORGOFF, I
    MOMAND, J
    DITTMER, D
    FINLAY, CA
    LEVINE, AJ
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1991, 56 : 219 - 225
  • [5] CELL-CYCLE, CANCER, SENESCENCE AND P53
    KAHN, A
    M S-MEDECINE SCIENCES, 1994, 10 (02): : 206 - 207
  • [6] P53 - THE MOLECULAR GUARDIAN OF CELL-CYCLE
    GUPTA, A
    SINGH, J
    CURRENT SCIENCE, 1995, 68 (11): : 1096 - 1103
  • [7] Phosphorylation of p53 serine 15 increases interaction with CBP
    Lambert, PF
    Kashanchi, F
    Radonovich, MF
    Shiekhattar, R
    Brady, JN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 33048 - 33053
  • [8] CHANGES IN P53 DURING THE CELL-CYCLE OF HUMAN KERATINOCYTES
    COTTON, J
    KUMAR, MG
    SPANDAU, DF
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 642 - 642
  • [9] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [10] Hypergravity induces phosphorylation of p53 at Serine 15, but not an expression of p53-downstream genes
    Okaichi, K
    Ide, M
    Usui, A
    Okumura, Y
    JOURNAL OF RADIATION RESEARCH, 2004, 45 (03) : 399 - 403